| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |